Aflibercept 83012-0052
Product NDC
83012-0052- Manufacturer
- Boehringer Ingelheim Fremont, Inc.
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- March 19, 2026
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Aflibercept | 65 mg/mL |
Packaging Options(1)
1000 mL in 1 BOTTLE (83012-052-99)